3902 — Medical Data Vision Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥19bn
- ¥17bn
- ¥6bn
- 94
- 20
- 17
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 658 | 1,077 | 1,592 | 1,427 | 1,568 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 262 | 53.5 | -47.5 | 300 | 234 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 101 | -325 | -597 | -966 | -287 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,202 | 964 | 1,083 | 911 | 1,616 |
Capital Expenditures | -81.3 | -27.1 | -24 | -53.2 | -30.2 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 50 | -116 | -2.89 | -816 | -408 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -31.3 | -143 | -26.9 | -869 | -438 |
Financing Cash Flow Items | 199 | — | -0.001 | 110 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 199 | -590 | -1,031 | -979 | -225 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,370 | 232 | 25.1 | -937 | 953 |